STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Outcomes In Children With Developmental Delay And Deafness

Phase 1

Completed

Conditions: Deafness
Hearing Loss

Interventions: Device: hearing aids
Device: cochlear implantation

First Posted Date: 2010-12-08

Last Posted Date: 2016-11-15

Lead Sponsor: Stanford University

Target Recruit Count: 303

Registration Number: NCT01256229

Locations: 🇺🇸
Baylor College of Medicine, Houston, Texas, United States
🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome

Phase 2

Completed

Conditions: Fragile X Syndrome

Interventions: Drug: placebo
Drug: oxytocin 24IU
Drug: oxytocin 48IU

First Posted Date: 2010-12-06

Last Posted Date: 2020-03-18

Lead Sponsor: Stanford University

Target Recruit Count: 10

Registration Number: NCT01254045

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Temperature Study in Cesarean Section

Not Applicable

Completed

Conditions: Hypothermia
Cesarean Section

Interventions: Other: Warmed fluids
Device: Belmont fluid warmer
Other: Fluid warmer and warming blanket
Device: Bair hugger warming blanket

First Posted Date: 2010-11-25

Last Posted Date: 2018-06-08

Lead Sponsor: Stanford University

Target Recruit Count: 46

Registration Number: NCT01249014

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery

Not Applicable

Completed

Conditions: Acute Kidney Injury

Interventions: Drug: Aminophylline
Drug: Placebo

First Posted Date: 2010-11-22

Last Posted Date: 2015-06-08

Lead Sponsor: Stanford University

Target Recruit Count: 144

Registration Number: NCT01245595

Locations: 🇺🇸
Lucile Packard Childrens' Hospital, Palo Alto, California, United States

Vivamos Activos Fair Oaks Program for Weight Loss in Low Income Latinos

Phase 2

Completed

Conditions: Obesity

Interventions: Behavioral: Vivamos Activos Fair Oaks Program

First Posted Date: 2010-11-17

Last Posted Date: 2014-06-02

Lead Sponsor: Stanford University

Target Recruit Count: 207

Registration Number: NCT01242683

Locations: 🇺🇸
Palo Alto Medical Foundation Research Institute, Palo Alto, California, United States
🇺🇸
El Concilio of San Mateo, San Mateo, California, United States
🇺🇸
San Mateo Medical Center, Fair Oaks Adult Clinic, Redwood City, California, United States

and more 1 locations

Study on the Effect of a Beta Blocker on Increased Sensitivity to Pain in Humans Caused by Opioids

Phase 2

Completed

Conditions: Hyperalgesia

Interventions: Drug: Propranolol
Drug: Placebo to Match Propranolol
Drug: Remifentanil

First Posted Date: 2010-10-18

Last Posted Date: 2018-06-15

Lead Sponsor: Stanford University

Target Recruit Count: 10

Registration Number: NCT01222091

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Environmental Strategies & Behavior Change to Reduce Overeating in Obese Children

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Standard Packard Pediatric Weight Control Program
Behavioral: Standard Packard Pediatric Weight Control Program plus Home-based advising on environmental changes

First Posted Date: 2010-10-14

Last Posted Date: 2021-05-07

Lead Sponsor: Stanford University

Target Recruit Count: 174

Registration Number: NCT01221220

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Phase 2

Terminated

Conditions: Leukemia
Acute-graft-versus-host Disease
Non-Hodgkin Lymphoma (NHL)
Hodgkin Lymphoma
Hematologic Diseases

Interventions: Drug: Sirolimus
Drug: Mycophenolate mofetil (MMF)
Drug: Carmustine
Drug: FTBI
Drug: Etoposide
Drug: Cyclophosphamide (Cyclo, CY)

First Posted Date: 2010-10-13

Last Posted Date: 2017-06-05

Lead Sponsor: Stanford University

Target Recruit Count: 3

Registration Number: NCT01220297

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Doctors and Web-based Self-management Support Pilot Study

Phase 3

Completed

Conditions: Diabetes Mellitus

Interventions: Behavioral: Online diabetes workshop observation and learning sessions

First Posted Date: 2010-10-13

Last Posted Date: 2016-04-19

Lead Sponsor: Stanford University

Target Recruit Count: 57

Registration Number: NCT01220310

Locations: 🇺🇸
O'Connor Hospital, San Jose, California, United States
🇺🇸
Alameda County Medical Center, Oakland, California, United States
🇺🇸
Santa Clara Valley Medical Center, San Jose, California, United States

and more 1 locations

Use of Symbicort or Pulmicort to Treat Viral-mediated Asthma Exacerbations

Not Applicable

Completed

Conditions: Asthma

Interventions: Drug: Symbicort

First Posted Date: 2010-10-11

Last Posted Date: 2017-08-18

Lead Sponsor: Stanford University

Target Recruit Count: 10

Registration Number: NCT01218399

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy